Your browser doesn't support javascript.
loading
Initial experience with scalp sparing radiation with concurrent temozolomide and tumor treatment fields (SPARE) for patients with newly diagnosed glioblastoma.
Song, Andrew; Bar-Ad, Voichita; Martinez, Nina; Glass, Jon; Andrews, David W; Judy, Kevin; Evans, James J; Farrell, Christopher J; Werner-Wasik, Maria; Chervoneva, Inna; Ly, Michele; Palmer, Joshua D; Liu, Haisong; Shi, Wenyin.
Affiliation
  • Song A; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Bar-Ad V; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Martinez N; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Glass J; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Andrews DW; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Judy K; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Evans JJ; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Farrell CJ; Department of Neurological Surgery, Thomas Jefferson University, Philadelphia, PA, USA.
  • Werner-Wasik M; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Chervoneva I; Department of Pharmacology & Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, Philadelphia, PA, USA.
  • Ly M; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Palmer JD; Department of Radiation Oncology, The Ohio State University, Columbus, OH, USA.
  • Liu H; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Shi W; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA. Wenyin.Shi@Jefferson.edu.
J Neurooncol ; 147(3): 653-661, 2020 May.
Article in En | MEDLINE | ID: mdl-32206976

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Antineoplastic Agents, Alkylating / Chemoradiotherapy / Temozolomide Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Main subject: Brain Neoplasms / Glioblastoma / Antineoplastic Agents, Alkylating / Chemoradiotherapy / Temozolomide Type of study: Clinical_trials / Diagnostic_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article